05:27 PM EST, 12/20/2024 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on December 20, 2024, sold 55,000 shares in Centessa Pharmaceuticals ( CNTA ) for $959,057. Following the Form 4 filing with the SEC, Saha has control over a total of 558,661 shares of the company, with 520,661 shares held directly and 38,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1847903/000184790324000186/xslF345X05/wk-form4_1734733345.xml